Biotech Business Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Business Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Business & Finance
Genzyme sees net income rise in first quarter
May 18th, 2006
Genzyme Corp. (GENZ) announced financial results for the first quarter of 2006. Revenue increased 16 percent to $730.8 million, up from $629.9 million in the same quarter a year earlier. GAAP net income rose to $101.0 million, or $0.37 per diluted share, compared with $95.6 million, or $0.36 per diluted share in the first quarter last year. GAAP earnings in the first quarter of 2006 reflect the implementation of FAS 123R related to expensing of stock options, which impacted results by $22.3 million net of tax, or $0.08 per diluted share. Non-GAAP net income - which excludes amortization, contingent convert, and the impact of FAS 123R - increased to...
Source: Biotech Business Week (2006-05-18)
|
